Eurofins MWG Operon Inc., a prominent player in the biotechnology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1998, the company has established itself as a leader in genomics and molecular biology, providing high-quality DNA sequencing, oligonucleotide synthesis, and custom gene synthesis services. With a commitment to innovation, Eurofins MWG Operon distinguishes itself through its advanced technologies and rigorous quality control processes. The company’s core offerings cater to a diverse clientele, including academic institutions, pharmaceutical companies, and research organisations, ensuring they meet the evolving demands of the life sciences industry. Recognised for its reliability and precision, Eurofins MWG Operon continues to solidify its market position, contributing significantly to advancements in genetic research and diagnostics.
We don't have data for Eurofins Mwg Operon Inc., but we can show you information about their parent organization instead.
View parent company